ImmunityBio
IBRX
$6.42
Share price
-2.87%
Change (1 day)
118.37%
Change (1 year)
Categories
ImmunityBio (IBRX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.09 B
According to ImmunityBio's latest financial reports the company's total liabilities are $1.09 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ImmunityBio - Total liabilities on balance sheet (from 2020 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.81 B | 13.94% |
| 2021-12-31 | $0.71 B | 109.73% |
| 2020-12-31 | $0.33 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | -97.97% | 🇺🇸 USA |